Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GI-5005 + SoC in Genotype 1 Chronic Hepatitis C
NCT00606086Phase 2Completed
- Sponsor
- GlobeImmune
- Start
- Dec 2007
- Primary completion
- Nov 2012
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of GI-5005 in hepatitis C (HCV), sponsored by GlobeImmune. Started Dec 2007; status: completed.
02
Drugs
GI-5005
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00606086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00606086.